Wai Chun Bio-Technology Limited reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was HKD 495.38 million compared to HKD 567.55 million a year ago. Net loss was HKD 17.03 million compared to HKD 8.15 million a year ago.

Basic loss per share from continuing operations was HKD 0.0102 compared to HKD 0.0049 a year ago.